Major shareholder announcement – BlackRock, Inc.
15 Mai 2024 - 11:45AM
Major shareholder announcement – BlackRock, Inc.
ANNOUNCEMENT NO. 266
Major shareholder announcement
Major shareholder announcement – BlackRock,
Inc.
Pursuant to Section 30 of the Capital Markets Act,
it is hereby announced that BlackRock, Inc. has informed ChemoMetec
A/S that BlackRock Investment Management (UK) Limited on 13 May
2024, decreased its holding of voting rights attached to shares and
voting rights in ChemoMetec A/S to below 10%, and that the holding
thus is below the 10 per cent limit in section 38 of the Capital
Markets Act.
The aggregate holding of shares and voting rights
of BlackRock, Inc. in ChemoMetec A/S amounts to 14,07% of the total
share capital and voting rights in ChemoMetec A/S.
Additional information
Niels Høy Nielsen, CFOTelephone (+45) 2551 8724
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets
instruments for cell counting and a wide range of other
measurements. ChemoMetec’s instruments are marketed to the
pharmaceutical, biotech and agricultural industries worldwide.
ChemoMetec was founded in 1997 and is listed on
Nasdaq OMX Copenhagen. For more information, go to
www.chemometec.com
Chemometec AS (TG:CHY)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Chemometec AS (TG:CHY)
Historical Stock Chart
Von Jun 2023 bis Jun 2024